Monoclonal antibody (mAb) MR6 recognises a 200 kDa glycoprotein, gp200-MR6, which is expressed at high levels on the surface of human thymic cortical epithelium. In order to produce further mAbs against the gp200-MR6 molecule, mice were immunised with purified human gp200-MR6, hybridomas produced and supernatants screened for MR6-1ike reactivity on human thymic sections. Surprisingly this conventional hybridoma technique failed to produce stable hybridoma cells producing MR6-1ike antibodies. However, antibodies with specificitie other than MR6-1ike were obtained. Three such antibodies (1B2, 3A3 and 4B3) were analysed further. Expression of 1B2-antigen, 3A3-antigen and 4B3-antigen was analysed on skin, tonsil and thymic sections, on cultured thymic epithelial cells (TEC), thymocytes and peripheral blood mononuclear cells (PBMC), and found to be expressed by both lymphocytes and epithelial cell populations. Furthermore, the antigens were also expressed on mouse thymic, epithelial cells. The regulation of expression of these antigens was analysed following mitogen or cytokine stimulation of PBMC and cultured TEC, respectively. Expression on T cells was clearly affected by mitogens that mimic activation through the T cell receptor and expression on cultured TEC was affected by T cell-derived cytokines. Thus, the shared epithelial-lymphocyte molecules identified in this study may play a role in the cross-talk between the developing thymocytes and their epithelial microenvironment. The production of mAbs with specificities other than that of purified gp200-MR6 indicates that a wide range of B ceils with specificity for components of the human thymic microenvironment exist in the normal mouse. These may detect epitopes that are shared with common pathogens to which the animals are exposed. Alternatively, they may be autoreactive B cells that are normally silent in the absence of T cell help. This help may be provided by T cells specific for human gp200-MR6, or nonspecifically by polyclonal activation induced by the adjuvant.
INTRODUCTION
The thymic microenvironment plays an important role in thymocyte development by providing signals regarding migration, differentiation, selection and proliferation. These signals may be mediated by soluble molecules produced by the stromal cells or by direct cell-cell interaction between surface molecules on the stromal cells and the thymocytes. However, little is known about the molecular mechanism involved.
One way of investigating such microenvironmental signals provided by the stromal cells is to analyse in detail their surface molecules using monoclonal antibody and phage display techniques (van Vliet et al., 1984; de Maagd et al., 1985; Boyd et al., 1993; Palmer et al., 1997) . The reagents generated in these studies have revealed significant molecular heterogeneity within the epithelial component of the thymic microenvironment.
Antibodies raised against the thymic epithelium of a variety of species, including human, have been divided into five major clusters of thymic epithelial staining (CTES) patterns (Kampin,ga et al., 1989; Ritter and Crispe, 1992) . CTES I antibodies are pan-epithelial, CTES II antibodies label subcapsular/perivascular and a major subpopulation of medullary epithelial cells, CTES III antibodies detect molecules on cortical epithelium, CTES IV antibodies label Hassall's corpuscles and all medullary epithelial cells, and CTES V reagents stain Hassall's corpuscles and sometimes a surrounding halo of medullary epithelial cells. However, for only few of these mAbs are their target antigens identified.
One such antibody is the mAb MR6. The molecule recognised by mAb MR6, gp200-MR6, is a 200 kDa glycoprotein expressed at high levels on the surface of human cortical epithelium and at much lower levels on macrophages, dendritic cells and thymocytes (Larch6 et al., 1988a; Mat et al., 1990) . Apart from the thymus the gp200-MR6 is expressed on peripheral lymphocytes and on epithelial cells in breast, colon and skin (Larch6 et al., 1988a; A1-Tubuly et al., 1996) . Since gp200-MR6 is shared by thymocytes and epithelial cells it was a potential candidate as a molecule participating in cell-cell cross-talk between the thymocytes and the epithelium. Functional analysis revealed that addition of mAb MR6 to cultures of T cell clones partially inhibited both antigen-and IL-2-induced proliferation and completely blocked IL-4-induced proliferation in a dose-dependent manner and that mAb MR6 completely abrogated the IL-4-dependent production of specific antigen-induced IgE by B cells (Larch6 et al., 1988a (Larch6 et al., , 1988b ). This dramatic influence on IL-4-dependent functions suggested that the gp200-MR6 was linked to the IL-4 receptor. Furthermore, mAb MR6 has been found to inhibit alloreactivity, probably via a block in the expansion of IL-4 responsive/secreting Th2 helper T cells (Imami et al., 1994 figure 5 ). All cells expressed the 3A3-antigen and 4B3-antigen, whereas the majority of the cells expressed the 1B2-antigen. As can be seen in figure 5 the expression was predominantly internal, although the staining pattern did vary for the different mAbs. MAbs 1B2 and 3A3 both stained all the cytoplasm, where lB2-antigen was expressed weakly, but quite homogeneously within the cells (figure 5A) compared to 3A3-antigen which was expressed strongly in patches (figure 5B). Expression of 4B3-antigen clearly had a granular pattern with the granules accumulating next to the nucleus (figure 5C). No staining was observed with the isotype matched antibody mAb 8D4 ( figure 5D ). For comparison, mouse thymic epithelial cells cultured in slide flasks were also stained with the new monoclonal antibodies (figure 6). Interestingly, the same staining pattern was obtained as with the human thymic epithelial cells. 
Regulation of Expression of the Molecules

DISCUSSION
Immunisation with purified gp200-MR6 was very successful. Already 10 days after the second immunisation, the sera from the mice contained large quantifies of MR6-1ike antibodies (effective in immunohistochemical staining at a dilution of 1/4000). In order to allow class switching and affinity maturation to occur, the mice were immunised twice more, at intervals of at least 2 weeks. All fusions resulted in production of hybridoma cells producing MR6-1ike antibodies. Unfortunately, these hybridoma cells always died, usually at the first cloning stage when cells started to proliferate in the small wells in the 96 well plates. It can be suggested that in the small wells the antibodies were present at high concentration and somehow toxic for the cells.
Since B cells use IL-4 as a growth factor it is possible that antibodies which cross-react with the murine gp200-MR6 molecule (i.e. autoreactive) were blocking cell growth. Thus, it seem likely that conventional hybridoma technology is unlikely to yield more MR6-1ike antibodies. This has, however, been successful using phage-display technology (Palmer et al., 1999) . Lymberi et al., 1989) . Interestingly, these auto-reactive hybridomas could be obtained from both primed and unprimed mice. Ritter and Boyd (1993) . Several such molecules (e.g. gp200-MR6 and MTS 12, 32, 33, 35 and 37) have been investigated in further details (Larch6 et al., 1988a; Tucek et al., 1992; A1-Tubuly et al., 1996) .
All three molecules recognised by mAbs 1B2, 3A3 and 4B3 are expressed predominantly internally. However, mAb 3A3 stained the surface of the squamous epithelium in the skin, as well as the cytoplasm. These are the most differentiated epithelial cells in the skin, suggesting that 3A3-antigen is transported out on the surface when the epithelial cells reach a more mature stage. The staining patterns on PBMC and cultured epithelial cells obtained by the different mAbs varied considerably. MAb 1B2 stained the cytoplasm quite homogeneously, mAb 3A3 stained patches in the cytoplasm very strongly as well as the area around/at the nuclear membrane and mAb 4B3 stained granules within the cytoplasm. The molecules may be part of the intracellular structure; however, the 3A3-antigen and 4B3-antigen are all expressed on lymphocytes and thymic epithelium, we analysed whether mitogens or cytokines would affect their expression on PBMC or cultured thymic epithelial cells, respectively. (Truneh et al., 1985) and cross-linking of membrane bound Ig (Gold et al., 1991) (1996) . Approximately 100 sections, 18 ktm thick, were cut in a cryostat, placed into an ice cold tube and then solubilised in 1.2 ml of lysis buffer (10 mM Tris-HC1, pH 7.2, containing 1% Nonidet P-40 and 1 mM phenylmethyl-sulfonyl fluoride) for 15 minutes on ice. The tubes were centrifuged at 10,000 rpm at 4C for 15 minutes. The supernatant, containing the solubilised gp200-MR6, was collected and either used immediately or stored at -20C.
The purification of gp200-MR6 was performed at 4C. 1 ml of thymic lysate was added into 500 tl of MR6-agarose. The well plate. The cells were cultured in medium alone (RPMI medium supplemented with 10% foetal calf serum) or in the presence of mitogens (Sigma), phytohemagglutinin (PHA), used at 2 ktg/ml, concanavalin A (Con A), used at 25 tg/ml, pokeweed mitogen (PWM), used at 2.5 ktg/ml, and phorbol 12-myristate 13-acetate (PMA), used at 10 ng/ml together with 1 tg/ml of the calcium ionophore ionomycin. The concentrations used were all within the range recommended by the manufacturer. Cells were harvested after 4, 24, 48 and 72 hours and analysed by immunofluorescenc and flow cytometry. Approximately 2 x 105 cells were incubated with mAbs (Dako) against CD3, CD23 (clone MHM6) or CD25 (clone ACT-l) for analysing surface expression or with hybridoma supernatants for internal and/or surface expression.
Thymic epithelial cells, growing in slide flasks, were cultured for 48 hours in the presence or absence of IL-2 (20 U/ml, Boehringer Mannheim, Lewes, England), (50 U/ml, Genzyme Diagnostics, Kings Hill, England), IL-13 (15 ng/ml, Pepro Tech, Rocky Hill, NJ, USA) or IFN-/ (100 U/ml, Genzyme). The cells were then stained by the indirect immunoperoxidase technique using hybridoma supernatants and analysed using light microscopy by two independent observers. The intensity of staining of untreated and treated cells was compared. Results were given as no change (no change in staining intensity), upregulation (increase in staining intensity) or downregulation (decrease in staining intensity).
